ABSTRACT
Twenty pediatric and 180 adult patients underwent myelography using metrizamide (Amipaque). All patients were examined and interviewed before and after the studies. New or exacerbated symptoms attributed to metrizamide myelography were graded according to severity. After the procedure, 51 of 200 patients were unchanged from baseline. Headache was the most common complaint, with an overall incidence of 62%. Nausea and/or vomiting occurred in 38%. Back or leg pain, neck stiffness, temperature elevation, and a variety of less common manifestations were also observed. The incidence of sequelae was higher than in comparable Scandinavian studies with this contrast medium.
Subject(s)
Metrizamide/adverse effects , Myelography , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Fever/chemically induced , Follow-Up Studies , Headache/chemically induced , Humans , Infant , Male , Middle Aged , Nausea/chemically induced , Vomiting/chemically inducedABSTRACT
A case of multiple giant cell tumors is reported. Neither of the lesions was malignant. The clinical, pathologic, and radiographic features of giant cell tumors are discussed.
Subject(s)
Bone Neoplasms , Giant Cell Tumors , Neoplasms, Multiple Primary , Adult , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/pathology , Giant Cell Tumors/diagnostic imaging , Giant Cell Tumors/pathology , Humans , Male , Neoplasms, Multiple Primary/diagnostic imaging , Neoplasms, Multiple Primary/pathology , RadiographyABSTRACT
An unusual presentation and treatment of an intranasal Schwannoma are discussed. The clinical and pathological features are also reviewed.
